%0 Journal Article %T Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. %A Janson ET %A Knigge U %A Dam G %A Federspiel B %A Grønbaek H %A Stålberg P %A Langer SW %A Kjaer A %A Arola J %A Schalin-Jäntti C %A Sundin A %A Welin S %A Thiis-Evensen E %A Sorbye H %J Acta Oncol %V 60 %N 7 %D Jul 2021 %M 33999752 %F 4.311 %R 10.1080/0284186X.2021.1921262 %X UNASSIGNED: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.
UNASSIGNED: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.